Cargando…

Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination

When the Mpox virus (MPXV) began spreading globally in 2022, it became critical to evaluate whether residual immunity from smallpox vaccination provided cross-protection. To assess the cross-immune response to MPXV, we collected serum samples (n = 97) and PBMCs (n = 30) from healthy-donors, either b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matusali, Giulia, Petruccioli, Elisa, Cimini, Eleonora, Colavita, Francesca, Bettini, Aurora, Tartaglia, Eleonora, Sbarra, Settimia, Meschi, Silvia, Lapa, Daniele, Francalancia, Massimo, Bordi, Licia, Mazzotta, Valentina, Coen, Sabrina, Mizzoni, Klizia, Beccacece, Alessia, Nicastri, Emanuele, Pierelli, Luca, Antinori, Andrea, Girardi, Enrico, Vaia, Francesco, Sette, Alessandro, Grifoni, Alba, Goletti, Delia, Puro, Vincenzo, Maggi, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610801/ https://www.ncbi.nlm.nih.gov/pubmed/37896943 http://dx.doi.org/10.3390/vaccines11101541

Ejemplares similares

Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up
por: Matusali, Giulia, et al.
Publicado: (2022)

Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN Vaccine
por: Matusali, Giulia, et al.
Publicado: (2023)

Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay
por: D’Apice, Luciana, et al.
Publicado: (2022)

SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel
por: Santoro, Annapaola, et al.
Publicado: (2023)

Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
por: Lapa, Daniele, et al.
Publicado: (2022)

Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination
por: Puro, Vincenzo, et al.
Publicado: (2021)

Vaxxing to elimination: smallpox vaccines as tools to fight mpox
por: Titanji, Boghuma K., et al.
Publicado: (2023)

Availability and Accessibility of Live Nonreplicating Smallpox/Mpox Vaccine
por: Kahn, Peter A., et al.
Publicado: (2023)

Efficacy of smallpox vaccines against Mpox infections in humans
por: Christodoulidou, Melissa M, et al.
Publicado: (2023)

Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway
por: D’Abramo, Alessandra, et al.
Publicado: (2022)

Lymphofollicular lesions associated with monkeypox (Mpox) virus proctitis
por: Mazzotta, Valentina, et al.
Publicado: (2023)

Tropism of the Chikungunya Virus
por: Matusali, Giulia, et al.
Publicado: (2019)

In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses
por: Najafi Fard, Saeid, et al.
Publicado: (2021)

SARS-CoV-2 Infection of Airway Epithelium Triggers Pulmonary Endothelial Cell Activation and Senescence Associated with Type I IFN Production
por: Bordoni, Veronica, et al.
Publicado: (2022)

Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2023)

Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf
por: De Clercq, Erik, et al.
Publicado: (2023)

Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world
por: Adetifa, Ifedayo, et al.
Publicado: (2023)

A Case of Severe Mpox Complicated with Streptococcus pyogenes Sepsis in a Patient with HIV Infection
por: Di Bari, Silvia, et al.
Publicado: (2023)

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
por: Agrati, Chiara, et al.
Publicado: (2022)

Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection
por: Colavita, Francesca, et al.
Publicado: (2023)

SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus
por: Matusali, Giulia, et al.
Publicado: (2021)

In Acute Dengue Infection, High TIM-3 Expression May Contribute to the Impairment of IFNγ Production by Circulating Vδ2 T Cells
por: Cimini, Eleonora, et al.
Publicado: (2022)

In Vitro and In Vivo Crosstalk between Type I IFN and IL-8 Responses in SARS-CoV-2 Infection
por: Biava, Mirella, et al.
Publicado: (2023)

Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus
por: Li, Entao, et al.
Publicado: (2023)

Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
por: Tortorella, Carla, et al.
Publicado: (2022)

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
por: Petrone, Linda, et al.
Publicado: (2021)

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
por: Lapa, Daniele, et al.
Publicado: (2022)

Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics
por: Colavita, Francesca, et al.
Publicado: (2020)

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2022)

Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19
por: Mazzotta, Valentina, et al.
Publicado: (2022)

Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test
por: Meschi, Silvia, et al.
Publicado: (2020)

Safety and Efficacy of Post-Eradication Smallpox Vaccine as an Mpox Vaccine: A Systematic Review with Meta-Analysis
por: Malone, Shelia M., et al.
Publicado: (2023)

Viral replication and infectivity of monkeypox through semen – Authors' reply
por: Lapa, Daniele, et al.
Publicado: (2022)

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
por: Agrati, Chiara, et al.
Publicado: (2022)

Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine
por: Agrati, Chiara, et al.
Publicado: (2021)

Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
por: Pittalis, Silvia, et al.
Publicado: (2022)

Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant
por: Bordi, Licia, et al.
Publicado: (2023)

Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysis
por: Sberna, Giuseppe, et al.
Publicado: (2022)

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
por: Aiello, Alessandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mnge1s6oh63vse600q8ktrlmrs